1087 related articles for article (PubMed ID: 16715031)
21. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.
Müller B; Becker KL; Schächinger H; Rickenbacher PR; Huber PR; Zimmerli W; Ritz R
Crit Care Med; 2000 Apr; 28(4):977-83. PubMed ID: 10809269
[TBL] [Abstract][Full Text] [Related]
22. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis.
Wacker C; Prkno A; Brunkhorst FM; Schlattmann P
Lancet Infect Dis; 2013 May; 13(5):426-35. PubMed ID: 23375419
[TBL] [Abstract][Full Text] [Related]
23. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response.
Tugrul S; Esen F; Celebi S; Ozcan PE; Akinci O; Cakar N; Telci L
Anaesth Intensive Care; 2002 Dec; 30(6):747-54. PubMed ID: 12500512
[TBL] [Abstract][Full Text] [Related]
24. Activated partial thromboplastin time waveform analysis: a new tool to detect infection?
Chopin N; Floccard B; Sobas F; Illinger J; Boselli E; Benatir F; Levrat A; Guillaume C; Crozon J; Négrier C; Allaouchiche B
Crit Care Med; 2006 Jun; 34(6):1654-60. PubMed ID: 16607236
[TBL] [Abstract][Full Text] [Related]
25. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis.
Dahaba AA; Hagara B; Fall A; Rehak PH; List WF; Metzler H
Br J Anaesth; 2006 Oct; 97(4):503-8. PubMed ID: 16849384
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
27. Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?
Shaaban H; Daniel S; Sison R; Slim J; Perez G
J Crit Care; 2010 Dec; 25(4):570-5. PubMed ID: 20435431
[TBL] [Abstract][Full Text] [Related]
28. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis.
Paosong S; Narongroeknawin P; Pakchotanon R; Asavatanabodee P; Chaiamnuay S
Int J Rheum Dis; 2015 Mar; 18(3):352-9. PubMed ID: 25469944
[TBL] [Abstract][Full Text] [Related]
29. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
[TBL] [Abstract][Full Text] [Related]
30. Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin.
Hoeboer SH; Alberts E; van den Hul I; Tacx AN; Debets-Ossenkopp YJ; Groeneveld AB
J Infect; 2012 May; 64(5):484-93. PubMed ID: 22248983
[TBL] [Abstract][Full Text] [Related]
31. Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evaluation.
Venkatesh B; Kennedy P; Kruger PS; Looke D; Jones M; Hall J; Barruel GR
Anaesth Intensive Care; 2009 Jan; 37(1):20-6. PubMed ID: 19157341
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic potential of endotoxin scattering photometry for sepsis and septic shock.
Shimizu T; Obata T; Sonoda H; Akabori H; Miyake T; Yamamoto H; Tabata T; Eguchi Y; Tani T
Shock; 2013 Dec; 40(6):504-11. PubMed ID: 24089007
[TBL] [Abstract][Full Text] [Related]
33. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.
Brunkhorst FM; Wegscheider K; Forycki ZF; Brunkhorst R
Intensive Care Med; 2000 Mar; 26 Suppl 2():S148-52. PubMed ID: 18470710
[TBL] [Abstract][Full Text] [Related]
34. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.
Rey C; Los Arcos M; Concha A; Medina A; Prieto S; Martinez P; Prieto B
Intensive Care Med; 2007 Mar; 33(3):477-84. PubMed ID: 17260130
[TBL] [Abstract][Full Text] [Related]
35. Searching for predictors of surgical complications in critically ill surgery patients in the intensive care unit: a review.
Meyer ZC; Schreinemakers JM; de Waal RA; van der Laan L
Surg Today; 2015 Sep; 45(9):1091-101. PubMed ID: 25860589
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in critically-ill, postoperative patients with suspected sepsis.
Li L; Zhu Z; Chen J; Ouyang B; Chen M; Guan X
Am J Med Sci; 2013 Mar; 345(3):178-84. PubMed ID: 22739556
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy and clinical relevance of an inflammatory biomarker panel for sepsis in adult critically ill patients.
Bauer PR; Kashyap R; League SC; Park JG; Block DR; Baumann NA; Algeciras-Schimnich A; Jenkins SM; Smith CY; Gajic O; Abraham RS
Diagn Microbiol Infect Dis; 2016 Feb; 84(2):175-80. PubMed ID: 26586579
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic value of procalcitonin in patients with septic shock.
Clec'h C; Ferriere F; Karoubi P; Fosse JP; Cupa M; Hoang P; Cohen Y
Crit Care Med; 2004 May; 32(5):1166-9. PubMed ID: 15190968
[TBL] [Abstract][Full Text] [Related]
40. The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.
Jensen JU; Lundgren B; Hein L; Mohr T; Petersen PL; Andersen LH; Lauritsen AO; Hougaard S; Mantoni T; Bømler B; Thornberg KJ; Thormar K; Løken J; Steensen M; Carl P; Petersen JA; Tousi H; Søe-Jensen P; Bestle M; Hestad S; Andersen MH; Fjeldborg P; Larsen KM; Rossau C; Thomsen CB; Ostergaard C; Kjaer J; Grarup J; Lundgren JD
BMC Infect Dis; 2008 Jul; 8():91. PubMed ID: 18620598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
